LymphomaPrognosisLymphoma, B-CellLymphoma, Non-HodgkinLymphoma, T-CellLymphoma, Large B-Cell, DiffuseLymphoma, FollicularEpidemiologyBurkitt LymphomaLymphoma, B-Cell, Marginal ZoneMolecular EpidemiologyLymphoma, Mantle-CellLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralLymphoma, AIDS-RelatedLymphoma, Large-Cell, AnaplasticHodgkin DiseaseLymphoma, Large-Cell, ImmunoblasticRetrospective StudiesIncidenceVincristineSurvival AnalysisSurvival RateTreatment OutcomeRisk FactorsNeoplasm StagingAntibodies, Monoclonal, Murine-DerivedTumor Markers, BiologicalPrednisoneImmunohistochemistryTranslocation, GeneticAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD20CyclophosphamideFollow-Up StudiesLymphoma, Extranodal NK-T-CellDoxorubicinSEER ProgramDisease-Free SurvivalTime FactorsChromosomes, Human, Pair 14PrevalencePolymerase Chain ReactionCombined Modality TherapyImmunophenotypingAntigens, CD30Herpesvirus 4, HumanChromosomes, Human, Pair 18Kaplan-Meier EstimateAge FactorsLymph NodesGene Expression Regulation, NeoplasticB-LymphocytesCentral Nervous System NeoplasmsUnited StatesSkin NeoplasmsCell Line, TumorGene RearrangementAntibodies, MonoclonalProspective StudiesAntineoplastic AgentsRecurrenceCohort StudiesThymus NeoplasmsFatal OutcomeEpidemiologic MethodsProto-Oncogene Proteins c-bcl-6Leukemia, Lymphocytic, Chronic, B-CellMultivariate AnalysisAge DistributionEye NeoplasmsStomach NeoplasmsRemission InductionNose NeoplasmsNeoplasmsDisease ProgressionDisease OutbreaksDNA, NeoplasmInfant, NewbornBreast NeoplasmsReed-Sternberg CellsGenotypeBiopsyProportional Hazards ModelsNeoplasm ProteinsEpstein-Barr Virus InfectionsPredictive Value of TestsIn Situ Hybridization, FluorescencePopulation SurveillanceRegistriesBias (Epidemiology)LeukemiaMycosis FungoidesRisk AssessmentNeoplasm Recurrence, LocalTransplantation, AutologousCase-Control StudiesPseudolymphomaTumor Cells, CulturedImmunoenzyme Techniques